Biologics Spine Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data byTim AllenMay 13, 2025
Spine Aclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar Discs byJosh SandbergMarch 4, 2024
Spine Top Stories Centinel Spine® to Host Major Worldwide Live Surgery Broadcast in Two-Day Meeting on Lumbar Disc Arthroplasty featuring prodisc® L Total Disc Replacement byJosh SandbergMay 23, 2023
Biologics Spine BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease byChris StewartApril 18, 2022
Biologics Spine BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program byJosh SandbergFebruary 16, 2022
Biologics Spine BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease byJosh SandbergDecember 21, 2021
Spine Top Stories Nocimed Announces Publication of Using Magnetic Resonance Spectroscopy to Identify Painful Lumbar Discs in the European Spine Journal byJosh SandbergAugust 23, 2019
Hospitals Spine Denver Back Pain Specialists Physicians Begin Enrollment in Stem Cell Therapy Study in Subjects with Chronic Back Pain byJosh SandbergJuly 28, 2015
